JP Morgan Chase & Co’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.07M | Buy |
|
|||||
|
2025
Q2 | $497K | Sell |
|
|||||
|
2025
Q1 | $450K | Buy |
|
|||||
|
2024
Q4 | $479K | Sell |
|
|||||
|
2024
Q3 | $700K | Buy |
|
|||||
|
2024
Q2 | $498K | Sell |
|
|||||
|
2024
Q1 | $582K | Sell |
|
|||||
|
2023
Q4 | $724K | Sell |
|
|||||
|
2023
Q3 | $2.62M | Buy |
|
|||||
|
2023
Q2 | $3.16M | Sell |
|
|||||
|
2023
Q1 | $2.91M | Buy |
|
|||||
|
2022
Q4 | $2.79M | Buy |
|
|||||
|
2022
Q3 | $3.41M | Sell |
|
|||||
|
2022
Q2 | $3.21M | Buy |
|
|||||
|
2022
Q1 | $1.23M | Sell |
|
|||||
|
2021
Q4 | $1.86M | Buy |
|
|||||
|
2021
Q3 | $1.63M | Buy |
|
|||||
|
2021
Q2 | $1.37M | Sell |
|
|||||
|
2021
Q1 | $2.18M | Buy |
|
|||||
|
2020
Q4 | $755K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $0 | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $20K | Sell |
|
|||||
|
2018
Q4 | $168K | Buy |
|
|||||
|
2018
Q3 | $213K | Buy |
|
|||||
|
2018
Q2 | $10K | Buy |
|